EP 4114983 A1 20230111 - METHOD FOR THE MODULATION OF CANCER TREATMENT BASED ON ANALYZING THE GUT MICROBIOME
Title (en)
METHOD FOR THE MODULATION OF CANCER TREATMENT BASED ON ANALYZING THE GUT MICROBIOME
Title (de)
VERFAHREN ZUR MODULATION EINER KREBSBEHANDLUNG BASIEREND AUF DER ANALYSE DES DARMMIKROBIOMS
Title (fr)
PROCÉDÉ DE MODULATION DU TRAITEMENT DU CANCER BASÉ SUR L'ANALYSE DU MICROBIOME INTESTINAL
Publication
Application
Priority
- US 202062986063 P 20200306
- EP 2021055556 W 20210305
Abstract (en)
[origin: WO2021176036A1] The present invention relates to a method for prognosing a response to a cancer therapy in a human patient, comprising the steps of a) detecting the alpha diversity of the gut microbiome in a sample obtained from said human patient, and b) prognosing the response to cancer therapy in said human patient, wherein a higher alpha diversity of the gut microbiome of said patient is indicative for a response to said cancer therapy, when compared to a non-responsive patient. The present invention further relates to improved treatment strategies for cancer based on the alpha diversity of the gut microbiome.
IPC 8 full level
C12Q 1/6886 (2018.01); C12Q 1/689 (2018.01)
CPC (source: EP)
C12Q 1/6886 (2013.01); C12Q 1/689 (2013.01); C12Q 2600/106 (2013.01)
Citation (search report)
See references of WO 2021176036A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
DOCDB simple family (application)
EP 2021055556 W 20210305; EP 21710267 A 20210305